Total medical devices industry deals for Q3 2019 worth $10.78bn were announced globally, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked a decrease of 40.6% over the previous quarter and a drop of 25% when compared with the last four-quarter average of $14.41bn.
In terms of number of deals, the sector saw a rise of 6.8% over the last four-quarter average with 379 deals against the average of 355 deals.
In value terms, North America led the activity with deals worth $9.14bn.
Medical devices industry deals in Q3 2019: Top deals
The top five medical devices deals accounted for 58.8% of the overall value during Q3 2019.
The combined value of the top five medical devices deals stood at $6.34bn, against the overall value of $10.78bn recorded for the month.
The top five medical devices industry deals of Q3 2019 tracked by GlobalData were:
1) Exact Sciences’ $2.8bn acquisition of Genomic Health
2) The $1.17bn acquisition of BioTek Instruments by Agilent Technologies
3) Siemens Healthineers’ $1.1bn acquisition of Corindus Vascular Robotics
4) The $775m acquisition of Hu-Friedy Manufacturing by Cantel Medical
5) Stryker’s acquisition of GYS Tech and Mobius Imaging for $500m.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.